Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example (PLoS ONE (2014) 9, 5 (e96316) DOI: 10.1371/journal.pone.0096316)

M. Burotto, J. Wilkerson, W. Stein, R. Motzer, S. Bates

Research output: Contribution to journalComment/debate

Original languageEnglish
Article numbere105179
JournalPLoS ONE
Issue number7
StatePublished - 31 Jul 2014

Cite this